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We assessed the ability of thymulin, a zinc-dependent nonapeptide produced by the thymic epithelial cells, to in­
fluence the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from dispersed anterior 
pituitary (AP) cells from young, adult, and senescent female rats. Perifusion of young and senescent AP cells with 
thymulin doses of 10~6 to 10-5 M gave a significant stimulatory response for LH but not FSH. Gonadotropin re­
lease was always lower in the senescent cells. AP cells from both age groups incubated with 10 8 to 10-3 M 
thymulin show ed a time- and dose-dependent response for both gonadotropins, with a maximal stimulation at 
10 7 M. Preincubation of thymulin w ith an antithymulin serum completely quenched the secretagogue activity of 
the hormone. Coincubation of thymulin w ith the secretagogue gonadotropin-releasing hormone (GnRH) revealed 
a synergistic effect on LH release and an additive effect on the release of FSH. The calcium chelator EGTA 
blocked the gonadotropin-releasing activity of thymulin in AP cells. The cAMP enhancers, caffeine, NaF, and for- 
skolin significantly increased the thymulin-stimulated release of gonadotropins. The inositol phosphate enhancer 
LiCl potentiated the action of thymulin on gonadotropins. It is concluded that the gonadotropin-releasing activity 
documented here for thymulin is an age- and receptor-dependent effect mediated in part by calcium, cAMP, and 
inositol phosphates.
THE immune system is functionally linked to the nervous and endocrine systems, thus constituting an integrated homeostatic network (1). Within this network, the interac­
tion between the endocrine thymus and the reproductive 
system appears to be particularly significant. Such interac­
tion became evident after the discovery of the congenitally 
athymie (nude) mouse in the mid 1960s (2). In this mutant, 
the homozygous (nu/nu) females have severe deficiencies in 
reproductive function in comparison with their phenotypi- 
cally normal heterozygous littermates (nu/+). The times of 
vaginal opening and first ovulation are delayed (3), fertility 
is reduced (4), and follicular atresia is increased such that 
premature ovarian failure results (5). Similar abnormalities 
result from neonatal thymectomy of normal female mice 
(6,7). Nude female mice show significantly reduced levels 
of circulating and pituitary gonadotropins, a fact that seems 
to be causally related to the reproductive derangements in 
these mutants (4). These and other early life dysfunctions 
have led some investigators to consider the nude mouse as a 
suitable model of thymus-dependent accelerated aging.
Interestingly, all of the above reproductive deficiencies 
can be prevented in nude mice by neonatal grafting of a nor­
mal age-matched thymus (8,9). It lias been also shown that 
the administration of certain thymic peptides can restore, at 
least in part, gonadotropin production in nude mice (10).
Among the thymic peptides with a reported ability to 
modulate luteinizing hormone (LH) release in vitro, thymu­
lin is of particular interest (11). Thymulin is a thymic hor­
mone involved in several aspects of intra- and extrathymic 
T-cell differentiation (12). Thymulin consists of a biologically 
inactive nonapeptide component (facteur thymique sérique or 
FTS) coupled in an equimolecular ratio to the ion zinc (13), 
which confers biological activity to this molecule (14). Thymu- 
lin is exclusively produced by the thymic epithelial cells (TEC) 
and its secretion declines steadily with age (15-17).
The control of thymulin secretion by TEC seems to be 
dependent on a complex network of events. Initial studies 
showed that the hormone itself exerts a controlling feedback 
effect on its own secretion both in vivo and in vitro (18,19). 
Additionally, thymulin production and secretion is influ­
enced directly or indirectly by the neuroendocrine system 
and gonadal steroids (reviewed in ref. 20).
In order to determine whether thymulin may influence 
follicle stimulating hormone (FSH) secretion (in addition to 
LH) and whether the gonadotropin-releasing activity of 
thymulin is due to a ligand-specific, second messenger-medi­
ated action, we undertook to study the mechanism of action 
of thymulin in vitro. Also, it was of interest to investigate 
whether the chronic hypothymic condition of old rats would 
be associated with altered gonadotropin responses to thymu­
lin. The present report describes our findings.
Methods
Jest Substances and Antibodies
Ionophore A23187, EGTA, caffeine, and rat gonadotro­
pin-releasing hormone (GnRH) were purchased from Sigma 
Chemical Company, St. Louis, MO, USA. FTS was synthe­
sized by Laboratoires Choay, Paris, France. A specific rab­
bit antiserum against thymulin, raised and previously char­
acterized, was used (21).
Preparation of Rat Median Eminence Extracts
Young animals were sacrificed by decapitation, their me­
dian eminence (ME) dissected, and homogenized in 1 mL 
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0.05M HC1 plus 1% w/v ascorbic acid per ME. After thor­
ough homogenization, the extract was frozen and thawed three 
times and then submitted to three 20-second sonication 
bursts, with 10-second intervals between bursts. Finally, the 
homogenate was centrifuged at 10,000 g for 15 minutes, and 
the clear supernatant, considered as undiluted, was aliquoted 
and stored at -70°C until use.
Cultures of TEC and Preparation of Supernatants
The BALB/c mouse and Wistar rat TEC lines. IT-76M1 
and IT-45R1, respectively, used in this study, were sponta­
neously obtained after continuous cultures of thymic stro­
mal cells. The epithelial nature of these TEC lines was dem­
onstrated by the presence of cytokeratin filaments and 
desmosomes (22,23). After trypsinization, all cultures were 
settled in RPMI 1640, pH 7.2, supplemented with 5% fetal 
calf serum, 100 IU/mL penicillin, and 100 p.g/mL strepto­
mycin, at 37°C in an atmosphere containing 5% CO2 and in­
cubated for 7 days. Twenty-four hours before supernatant 
collection, culture medium was removed and replaced by 
serum-free medium. Supernatants were collected and frozen 
at -20°C until use.
Animals
Young (4 months), adult (10 months), and senescent (29— 
33 months) female Sprague-Dawley rats, raised and kept in 
our animal breeding facilities, were used. Animals were 
housed in a temperature-controlled room (22 ± 2°C) on a 
14:10 horn light/dark cycle. Food and water were available 
ad libitmn.
Cell Dispersion
Animals were sacrificed by decapitation and their ante­
rior pituitaries (AP) rapidly dissected. Ten to 12 AP were 
cut into 8 to 10 pieces each with a razor blade and placed to­
gether in a Petri dish where they were washed twice with 
Earle’s Balanced Salt Solution (EBSS) containing 1 g/L 
glucose. 1 g/L NaCO3H. 0.5% bovine serum albumin, 30 
|xg/mL ascorbic acid. 1.8 X 10 3 M CaCl2 and 50 IU/mL 
aprotinin (perifusion medium, PM). The pieces were trans­
ferred to a plastic tube containing 10 mL PM (without apro- 
tinin) with 30 mg collagenase type IV and 1 mg DNase type 
I (Sigma). After 1 horn’s incubation at 37°C under constant 
shaking, the cell suspension was repeatedly flushed with a 
Pastern pipette to complete the dispersion process. The sus­
pension was centrifuged at 500 g for 20 minutes at 4°C. The 
cell pellet was gently resuspended in 4 mL PM, an aliquot 
was mixed with an equal volume of 0.4% Trypan Blue in 
saline, and the mixture used for cell viability assessment. 
Cell viability ranged from 87 to 95% and was similar for 
young and senescent animals. Another aliquot was homoge­
nized and used to determine cell DNA content by a mi- 
crofluorometric method using /ris-benzimidazole (Hoechst 
H33258) as a fluorophor (24).
Cell Perifusion
Dispersed AP cells obtained as described above were 
packed with Biogel P-2 into short colmnns kept in a water 
bath at 37°C and continuously perifused with PM. The sub­
stances to be tested (stimuli) were dissolved in PM and. at 
appropriate times, a pulse of 2.5 mL per stimulus was 
pumped through the perifusion circuit, at the end of which 
1.5-mL fractions were collected with two synchronized 
fraction collectors every 2 minutes. ME extract was rou­
tinely used at the beginning and at the end of each experi­
ment as a system performance control. The quantity of LH 
or FSH released by each stimulus was assessed by radioim­
munoassay (RIA) with the materials obtained through the 
National Hormone and Pituitary Program (NHPP), NIDDK, 
NICHD, USDA. Hormone secretion was expressed as ng 
LHorFSH/pig cell DNA.
Cell Incubation
Dispersed AP cells were obtained as described above but 
from six to seven AP per experiment, and were placed into 
Eppendorf tubes (200 p.L/tubc). The tubes were placed in a 
metabolic incubator and preincubated at 37°C for 20 min­
utes under continuous shaking. At the end of the preincuba­
tion period, the tubes were centrifuged at 1,000 g for 2 min­
utes. Pellets were gently resuspended in PM containing the 
appropriate concentration of the different stimuli (tested in 
duplicates). Cells were incubated for the indicated times and 
centrifuged at 1,000 g for 2 minutes. Gonadotropins were 
determined in supernatants.
Statistics
Assessment of the level of significance of differences be­
tween stimulated and basal levels of gonadotropins released 
by AP cells was carried out by one-way analysis of variance 
(ANOVA). When more than one age group was studied, data 
were assessed by two-way ANOVA, taking “age” as factor 
A and “stimulus” as factor B. When appropriate. ANOVAs 
were followed by the Duncan’s multiple range test to assess 
the significance of differences between means. A p value 
lower than .05 was considered to be significant in all cases.
Results
Dynamic Studies
A perifusion system was first used in order to evaluate 
AP cell response to test substances under conditions (con­
tinuous flux of medium and short secretagogue pulses) that 
minimize paracrine influences on gonadotrophic cells. Me­
dian eminence extract was used in the perifusion experi­
ments as a reference secretagogue in order to check that AP 
cells at the beginning and at the end of the perifusion exper­
iments had comparable responses to a strong physiological 
stimulus. A 2 X 9 two-way ANOVA for each hormone re­
vealed that basal LH and FSH secretion of AP cells from se­
nescent rats was lower than that of their young counterparts 
(p < .01 for factor Age in both ANOVAs; for factor Stimu­
lus. p < .01 and < .05 for LH and FSH, respectively; for in­
teraction. p > .05 and < .05 for LH and FSH, respectively; 
also see Figure 1). Thymulin stimulated LH but not FSH re­
lease at 10 6 M (p < .05 [Duncan’s test]) and 10-5 M (p < 
.01), whereas its separate components. FTS (10 s M) and 
ZnCl2 (0.86 p.g/mL). were inactive by themselves. TEC su­
pernatants from both rat and mouse origin were also effec­
tive in stimulating LH (p < .01), but not FSH release. The 
gonadotropin secretory responses to ME extracts run through
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Figure 1. Profiles of LH (upper) and FSH (lower) release in perifusates of pituitary cells from young and senescent female rats. Cells were 
perifused with 10 5 M FTS, 0.86 |j.g/nil ZnCl2, the indicated doses of thymulin, undiluted mouse and rat thymic epithelial cell (TEC) superna­
tants, and median eminence (ME) extract 1/30 v/v. the latter used as a positive control. Arrows indicate the point at which the corresponding 
stimuli were applied. Data points and bars represent the mean ± SEMof 12 and 6 perifusion experiments for young and senescent pituitary do­
nors, respectively. (O—O) young group: (•—•) senescent group.
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the columns at the beginning and at the end of the experi­
ments were comparable. The gonadotropin responses of the 
cells from senescent rats were always lower than those of 
their young counterparts.
Time Course and Dose-Response Studies
Incubation experiments were carried out in order to ex­
pose cells for longer times than in perifusion studies to dif­
ferent doses of thymulin. In young rats, thymulin stimulated 
LH and FSH release in a time-dependent manner (data not 
shown). AP cells from senescent rats also showed a time­
dependent response to thymulin, although the magnitude 
was lower than in young cells (data not shown). The dose­
response pattern of gonadotropins to thymulin was bell­
shaped with a maximum around 10 7 M in both young and 
senescent cells, with the latter displaying lower responses at 
all doses tested (p < .01 for factor Age in the 2x7 two- 
way ANOVAs for LH and FSH; also see Figure 2).
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Thymulin (- logM)
Figure 2. Dose-response profiles of thymulin concentration versus 
LH or FSH release after 40 minutes' incubation of young (solid bars) 
and senescent (hatched bars) AP cells. Data points and bars repre­
sent the mean ± SEM of six sets of incubation experiments. M, 
thymulin molarity (mol/L).
Combined Effects of Thymulin and GnRH on 
Gonadotropin Secretion
When AP cells obtained from young, adult, or senescent 
rats were incubated with thymulin plus the natural gonado­
tropin secretagogue GnRH, the LH responses were syner­
gistic, whereas the FSH responses were approximately addi­
tive (Table 1). The response of both young and adult 
pituitary cells to the separate stimuli or their combinations 
were similar, but the release of LH and FSH from senescent 
cells was significantly diminished in all cases.
Blocking Experiments
Preincubation of thymulin or rat TEC supernatants with 
antithymulin rabbit serum (1/500) completely blocked the 
gonadotropin-releasing activity of these stimuli in young pi­
tuitary cells (Figure 3). The same results were obtained us­
ing concentrations of thymulin ranging from 10 s to 10 3 M 
(data not shown). The antithymulin serum per se did not in­
fluence the basal secretion of gonadotropins, whereas nor­
mal rabbit serum failed to display any blocking activity.
Signal Transduction Pathways Involved in the 
Gonadotropin Releasing Activity of Thymulin
The incubation of young AP cells with the calcium chela­
tor EGTA (5 mM) completely blocked the stimulatory ef­
fect of thymulin on gonadotropin release, whereas the pres­
ence of the calcium ionophore A23187 (5 p.M) had no 
effect on thymulin-stimulated gonadotropin secretion (Fig­
ure 4). On the other hand, LiCl, an inhibitor of inositol 
phosphate phosphatases, did not affect gonadotropin release 
per se (data not shown), but was able to potentiate the stim­
ulatory effect of thymulin on gonadotropin release. The pro­
tein kinase C inhibitor trifluoperazine (TFP) did not modify 
the thymulin-stimulated release of gonadotropins (Figure 4).
Caffeine and NaF, two intracellular cAMP enhancers 
which act at proximal and distal sites, respectively, of the 
cAMP pathway, did not affect, per se, gonadotropin release 
(data not shown), but potentiated the stimulatory effect of 
thymulin on LH and FSH secretion (Figure 4). The ade­
nylate cyclase activator forskolin, but not its inactive deriv­
ative 1,9-dideoxyforskolin, increased gonadotropin release 
in nonstimulated AP cells (data not shown). Forskolin po­
tentiated the stimulatory effect of thymulin on gonadotropin 
release (Figure 4).
Discussion
The present study docmnents that the metallopeptide 
thymulin possesses gonadotropin-releasing activity on AP 
cells in vitro under dynamic and stationary conditions. In 
perifusion, the clearance rate is equal to the flow rate of the 
system and is the same for all secreted products. Therefore, 
there is no influence of cell-secreted substances (25). Para­
crine interactions appear at flow rates of 1-5 mL/h (26), 
which is much slower than the flow rate used in our perifu­
sion model (0.7-0.8 mL/min). It is therefore unlikely that 
the gonadotropin-releasing activity of thymulin and TEC 
supernatants on our perifused AP cell preparations may 
have been exerted through paracrine influences on gonado­
trophs by factors released from nongonadotrophic cells in 
response to thymulin. Our findings are in line with a previ­
ous study in which thymulin was reported to stimulate LH 
release from perifused rat pituitary fragments. The glands 
responded in a dose-dependent manner with a maximal LH 
release at a thymulin concentration of 10 s M and a mini­
mal effective dose around 10 7 M thymulin (11). Although 
these doses are substantially higher than normal levels of 
circulating thymulin, approximately 70 X 10 14 M and 6 X 
10 14 M in young and old rats, respectively, as determined 
by bioassay (16), it is interesting to note that TEC superna­
tants, which possess physiological concentrations of thymu­
lin, were also effective in stimulating gonadotropin secretion. 
One possible explanation for this apparent inconsistency is 
that TEC may co-secrete factors that act synergistically with 
thymulin. Also, it is important to take into account that 
while the bioassay most likely measures free (bioactive) 
thymulin, which represents a very small fraction of total cir­
culating thymulin, our data represent total thymulin, most of 
which is probably bound to albmnin. In any case, it is un-
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Table 1. Combined Effect of Thymulin With GnRH on LH and FSH Release by AP Cells From Female Rats of Different Ages
Hormone Stimuli Young (6) Middle age (8) Senescent (6)
LH Medium (basal) 4.2 ± 0.8 3.6 ± 0.6 1.5 ± 0.3*
NIE extract 151.3 ± 11.8+ 160.0 ± 7.1 + 35.7 ± 3.2**+
GnRH 76.8 ± 3.5 + 71.5 ± 4.1 + 18.9 ± 1.8**+
Thymulin 59.3 ± 3.6+ 62.9 ± 3.1 + 14.3 ± 2.3**+
Thymulin plus GnRH 197.1 ± 9.0+ 191.4 ± 6.2+ 48.7 ± 3.4**+
FSH Medium (basal) 2.6 ± 0.5 2.1 ± 0.3 1.1 ± 0.2*
NIE extract 37.3 ± 4.2+ 35.8 ± 3.5 + 6.8 ± 0.3**+
GnRH 20.1 ± 2.8+ 22.6 ± 2.5 + 4.9 ± 0.8**+
Thymulin 17.8 ± 2.1 + 18.4 ± 1.9+ 4.4 + 0.4* *+
Thymulin plus GnRH 36.1 ± 4.4+ 35.7 ± 3.8+ 8.8 ± 0.5**+
Notes: Numbers in parentheses represent the n value of each group. The numeric values represent the amount of either LH or FSH (mean ± SEM), in ng/ 
p,g cell DNA, released by the pituitary cells incubated for 40 minutes. For each gonadotropin, data were analyzed using a 3 X 5 two-way ANOVA followed 
by Duncan’s multiple range test. Raw data were subjected to logarithmic transformation to achieve homogeneity of the variance.
+p < 0.05; +p < .01, when compared to their basal level.
*p < .05; **p < .01, when each stimulus is compared with the young counterparts.
likely that thymulin is a major stimulator of gonadotropin 
secretion because if so. a self-potentiating stimulatory loop 
would exist between thymulin and gonadotropins. A modu­
latory role of thymulin on gonadotropin secretion appears as 
a more plausible alternative.
The fact that FTS or Zn2 . separately, were inactive is in 
line with previous studies showing that FTS requires Zn2 
to exert its biological effect on lymphocytes (3). The rela­
tive gonadotrophic cell number, but not the secretory activ­
ity, declines with age in Sprague-Dawley rats (27). There­
fore. the lower LH responses to thymulin of the perifused 
AP cells from senescent animals, as compared to their 
young counterparts, is probably due to a reduced proportion 
of gonadotrophic cells in these preparations. On the other 
hand, perifused FSH cells appeared to be unresponsive to 
thymulin irrespective of the age of the donors. However, it 
should be pointed out that due to our small sample size, a 
minor sitimulatory effect of thymulin on FSH may have 
been missed. It also should be noted that the significance of 
the main ‘age effect’ detected by the statistical analysis does 
not imply that a significant difference exists at all doses.
It should be pointed out that at 10 months of age. a time 
at which thymus involution is significant and circulating 
thymulin levels have fallen markedly (28), incubated gonad­
otrophs showed the same response to thymulin (and to ME 
and GnRH) than the 4-month-old cells (Table 1). This indi­
cates that the chronically low serum levels of thymulin to 
which gonadotrophic cells from adult rats were exposed did 
not modify their responsiveness to the thymic hormone.
Our time-course experiments showed that gonadotrophic 
cells responded to thymulin in a time-dependent manner at 
several doses and that age changed the magnitude but not 
the shape of this response. The same is true for the bell­
shaped dose-response of gonadotropins to thymulin in incu­
bated AP cells. Many immune-derived peptides, such as in­
terleukins. are able to elicit bell-shaped dose-responses for 
the release of hypothalamic hormones (29). The facts that in 
the perifusion experiments the dose-response behavior of 
LH was logarithmic rather than bell-shaped and that FSH 
did not respond at all to thymulin were probably due to the 
lack of paracrine interactions in our perifusion system. 
Likewise, the observed displacement of the secretory LH 
curve towards higher concentrations in the perifusion sys­
tem may be due to the continuous washing of the perifused 
cells and. consequently, to shortened interaction times of 
the secretagogues with their target cells.
The fact that the stimulatory effect of TEC supernatants 
was blocked by antibodies antithymulin indicates that most 
of the secretagogue activity of TEC supernatants is due to 
the presence of thymulin. The specificity of the action of 
thymulin on gonadotropin secretion becomes clear from the 
blocking experiments shown in Figure 3 as well as from the 
fact that FTS or Zn 2 per se were inactive on gonadotropin 
release. This specificity as well as the dose-dependency of 
the gonadotropin-releasing activity of thymulin suggest the 
existence of receptor sites for this metallopeptide on AP 
cells. In two tumor-derived human T cell lines, two types of 
receptor for thymulin were found. One of high affinity 
A'j= 3.5 nM) and another of low affinity (A’d 100 nM). 
No cooperative effects between receptors were detected 
(30,31).
The stimulation of gonadotropin release by GnRH is 
known to be mediated by increased intracellular calcium as 
well as by increased intracellular levels of diacylglycerol 
(DAG) and inositol triphosphate (IP3). The latter induces a 
rhythmic release of calcium from an IP3-sensitive store 
which is coupled to a GnRH-stimulated gonadotropin burst 
of exocytosis (32,33).
Our data showing a synergistic effect of thymulin with 
GnRH on LH release and an additive effect for FSH imply 
that thymulin and GnRH do not share proximal steps of 
their signal transduction pathways. Our pharmacological 
experiments with EGTA and EGTA plus the calcium iono­
phore A23187 indicate that the gonadotropin-releasing ac­
tivity of thymulin is dependent on the presence of appropri­
ate levels of extracellular calcium. The cation Li+, known to 
increase the intracellular levels of inositol phosphates be­
cause of its ability to inhibit at least two inositol phosphate 
phosphatases, potentiated (this term is used because, whereas 
LiCl alone had no effect on gonadotropin release, thymulin 
plus LiCl had a significantly higher effect on gonadotropin 
release than thymulin alone) the effect of thymulin on gona-
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Figure 3. Immunoneutralization of the LH- and FSH-releasing ac­
tivity of thymulin and TEC supernatants (upper and lower panels, re­
spectively). Young AP cells were incubated for 40 minutes with ei­
ther medium alone (open bars), 10 7 M thymulin (solid bars), or 
undiluted rat TEC supernatant (hatched bars). Stimuli were preincu­
bated for 3 hours with the indicated sera (1/500). Data points and 
bars represent the mean ± SEM of six sets of incubation experi­
ments. Six individual one-way ANOVAs were performed: *p < .05: 
**p < .01, for comparisons of stimuli with their corresponding con­
trols (medium alone). When necessary, raw data were subjected to 
logarithmic transformation to achieve homogeneity of the variance.
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Figure 4. Effect of different pharmacologic substances on 10 1 M 
thymulin-stimulated LH and FSH release by AP cells incubated for 
40 minutes in the presence of the indicated stimuli (A = ionophore 
A23187). LH data are shown in the upper panel whereas FSH data 
are shown in the lower panel. Data points and bars represent the 
mean ± SEM of six sets of incubation experiments (54 young rats). 
For each gonadotropin, data were analyzed using a one-way 
ANOVA across all conditions (p < .001 in both cases), followed by 
Duncan's multiple range test. Except for the groups involving EGTA, 
differences with the corresponding basals were highly significant (p < 
.01). Also, for both hormones, differences between thymulin alone 
and thymulin + LiCl (or caffeine or NaF or forskolin) were highly 
significant (p < .01).
dotropin release. This supports the idea that phosphoinosi­
tides are involved in the secretagogue action of thymulin. The 
potentiation (see above) of thymulin-stimulated release of 
gonadotropins induced by intracellular cAMP enhancers 
like caffeine. NaF, and forskolin suggests that cAMP may 
be involved in the signal transduction pathway activated by 
thymulin in AP cells and is in line with a previous report in­
dicating that thymulin, at doses comparable to those in this 
report, increases intracellular cAMP in AP cells (34). In the 
immune system, indirect evidence has been reported sug­
gesting that cAMP could be a second messenger of thymu­
lin because cAMP could mimic the effect of this peptide on 
T lymphocytes (35).
The finding that TFP did not affect the gonadotropin re­
sponse of pituitary cells to thymulin suggests that the dia­
cylglycérol pathway is not involved in the action of this thy­
mic hormone. Whether the action of thymulin involves 
other second messengers such as cGMP remains to be in­
vestigated. Nevertheless, there is indirect evidence that this 
nucleotide is not involved in the activation of T lympho­
cytes by thymic extracts (35).
Taken together, the present results suggest that the gonad­
otropin-releasing activity documented here for thymulin is a 
receptor-mediated effect which is effected in part by cal­
cium, cAMP, and inositol phosphates. This mechanism of 
action of thymulin on gonadotrophs seems to be coimnon to 
other pituitary cell populations which have been recently 
shown to be responsive to this thymic peptide (34,36,37).
Although the cloning of the gene for thymulin has re­
mained elusive so far, it is unlikely that this molecule repre­
sents a cleavage product of some endogenous protein: a 
computer search of the protein database FASTA (38) which 
gives access to all known amino acid sequences through the 
protein databases Swiss-prot and NBRF/PIR, revealed that 
there are only eight proteins possessing any sequence in 
coimnon with thymulin. None of these sequences cone-
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sponds to mammalian proteins. Within this context, the hy­
pophysiotrophic activity of thymulin probably reflects the 
existence of a modulatory feedback loop of the pituitary- 
thymic axis. This loop does not seem to be disrupted by the 
early onset of thymus involution. Only when pituitary cell 
function becomes compromised, in very old rats, does this 
circuit deteriorate.
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